Pfizer pipelineFound 8 free book(s)
Pfizer Pipeline Snapshot 4 Pipeline represents progress of R&D programs as of January 31, 2017 Included are 62 NMEs, 26 additional indications, plus 8 biosimilars
6 YEAR 2017 IN REVIEW J& Shortly after Merck’s announcement, Pfizer informed that they are seeking a buyer for their consumer health business.
A Research-Driven and Product Focus Company. An approved product A high value pipeline A productive R&D platform. Restricted & Confidential. 3
Fortune.com - Fortune 500: Full List 1-100 http://www.fortune.com/fortune/subs/fortune500/top500/0,23613,,00.html 1 of 4 11/27/2005 3:58 PM · Try 3 Issues Free
Strategic Analysis of the Pharma Market, Future Revenue Models and Key Players 2 “Personalised medicine is a laudable aim, but we are not anywhere near there yet…
Vifor Pharma Ltd. Annual Report 2017 3 172 02 2017 at a glance 03 Table of contents 04 Ee ivexcut maegsse 08 Highlighs t 10 Our vision, mission and strategy 14 Perorf manceoeervwi v 18 Key medium-term growth drivers and products 20 – aferect In®j ®/ect nFerj i 26 – Vifor Fresenius Medical Care Renal Pharma 30 – Veltassa® 32 – eivsect …
4 36 Vifor Pharma Ltd. Annual Report 2017 ExECUTiVE MESSAGE 172 ExECUT iVE CHA iRMAN Dear Shareholder, It is with great pleasure that I deliver my message as Executive Chairman for the first time following the